NCT00479778View on ClinicalTrials.gov

Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

July 31, 2007

Conditions
Postmenopause
Interventions
DRUG

Bazedoxifene/conjugated estrogens

Trial Locations (1)

32608

Gainesville

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00479778 - Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms | Biotech Hunter | Biotech Hunter